Weed (BUDZ) Operating Income Growth (3y) (2020 - 2026)
Weed (BUDZ) Operating Income Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 29.31% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 4.24% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.90% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.82% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -74.25% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 27.21% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 35.42% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Weed | 3.13 Mn | 3.13 Mn | - | 16.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.76% |
| Dec 31, 2025 | -36.02% |
| Sep 30, 2025 | 37.80% |
| Jun 30, 2025 | 38.65% |
| Mar 31, 2025 | 6.46% |
| Dec 31, 2024 | 34.87% |
| Sep 30, 2024 | 18.30% |
| Jun 30, 2024 | 50.67% |
| Mar 31, 2024 | 44.04% |
| Dec 31, 2023 | 45.74% |
| Sep 30, 2023 | -3.52% |
| Jun 30, 2023 | 34.53% |
| Mar 31, 2023 | 61.00% |
| Dec 31, 2022 | 53.77% |
| Sep 30, 2022 | 64.45% |
| Jun 30, 2022 | 61.56% |
| Mar 31, 2022 | 63.73% |
| Dec 31, 2021 | 59.94% |
| Sep 30, 2021 | 71.68% |
| Jun 30, 2021 | 49.51% |